“Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience”, a retrospective study-original article

BACKGROUND: The first case of Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was diagnosed in Wuhan, China in 2019. In the first half of 2020, this disease has already converted into a global pandemic. This study aimed to find that treatment of patients with COVID-19 pne...

Descripción completa

Detalles Bibliográficos
Autores principales: Chachar, Aijaz Zeeshan Khan, Khan, Khurshid Ahmed, Iqbal, Javeid, Shahid, Adnan Hussain, Asif, Mohsin, Fatima, Syeda Arzinda, Khan, Asma Afzal, Younis, Bilal Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Experimental Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869677/
https://www.ncbi.nlm.nih.gov/pubmed/33585031
http://dx.doi.org/10.1016/j.amsu.2021.02.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869677/
https://www.ncbi.nlm.nih.gov/pubmed/33585031
http://dx.doi.org/10.1016/j.amsu.2021.02.011

Ejemplares similares